ZYVERSA THERAPEUTICS, INC. Deferred Income Tax Liabilities, Net
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Deferred Income Tax Liabilities, Net of $851.66 thousand as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-03-31
- 2025-06-30: Deferred Income Tax Liabilities, Net $851.66K.
- 2025-03-31: Deferred Income Tax Liabilities, Net $851.66K.
- 2024-12-31: Deferred Income Tax Liabilities, Net $851.66K.
- 2024-09-30: Deferred Income Tax Liabilities, Net $854.62K.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2025-06-30 | $851.66K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $851.66K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $851.66K 10-K · filed 2026-03-31 |
| 2024-09-30 | $854.62K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $854.62K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $844.91K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $844.91K 10-K · filed 2025-03-27 |
| 2023-09-30 | $1.44M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.44M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $9.28M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $10.32M 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |